Alopecia Areata

Clinical research study in alopecia areata (AA)

The Allegro 2b/3 research study aims to find out if an investigational medication can help treat people with AA who have lost 50% or more of the hair on their head.

During the course of this study, some people will receive the investigational medication and some will receive an inactive medication called a placebo. The study will explore whether the study drug is safe and can help AA patients regrow hair.

The study drug, using different doses, will be compared to an inactive placebo (dummy drug).

Study entry criteria

You may qualify for the Allegro 2b/3 study if you meet the following criteria:

  • are 12 years of age or older
  • have been diagnosed with alopecia areata (AA)
  • have at least 50% scalp hair loss*

*study doctor will assess your amount of hair loss.

In addition, other study entry criteria will need to be met in order to take part in the Allegro 2b/3 study - your doctor will be able to explain these to you.

How to see if you are elgible

If you are interested in joining the Allegro 2b/3 study, or have any questions, please call 208-955-9030.